{
    "Trade/Device Name(s)": [
        "MAGLUMI 2000 TSH",
        "MAGLUMI 2000 Immunoassay Analyzer",
        "MAGLUMI 2000 Immunoassay System"
    ],
    "Submitter Information": "Shenzhen New Industries Biomedical Engineering Co., Ltd.",
    "510(k) Number": "K162698",
    "Predicate Device Reference 510(k) Number(s)": [
        "K083844",
        "K151792"
    ],
    "Regulatory Class": "Class II (assay); Class I (instrument)",
    "Product Code(s)": [
        "JLW",
        "JJE"
    ],
    "Summary Letter Date": "May 29, 2017",
    "Summary Letter Received Date": "June 5, 2017",
    "Submission Date": "July 12, 2017",
    "Regulation Number(s)": [
        "21 CFR 862.1690",
        "21 CFR 862.2160"
    ],
    "Regulation Name(s)": [
        "Thyroid stimulating hormone test system",
        "Analyzer, Chemistry (Photometric, Discrete), For Clinical Use"
    ],
    "Analyte Class(es)": [
        "endocrine"
    ],
    "Analyte(s)": [
        "Thyroid-stimulating hormone (TSH)"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [
        "Sample cups",
        "Primary tubes"
    ],
    "Instrument(s)/Platform(s)": [
        "MAGLUMI 2000 Immunoassay System"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay"
    ],
    "Methodologies": [
        "Sandwich chemiluminescent immunoassay"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Assay",
        "Reagent",
        "Calibrator",
        "Control",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for MAGLUMI 2000 TSH chemiluminescent immunoassay and automated analyzer system for quantitative determination of TSH in human serum",
    "Indications for Use Summary": "In vitro quantitative determination of thyroid-stimulating hormone (TSH) in human serum to aid in the diagnosis of thyroid disorders, using the MAGLUMI 2000 Immunoassay System",
    "fda_folder": "Clinical Chemistry"
}